Volgen
Michael Lanuti
Michael Lanuti
Associate Professor of Surgery, Harvard Medical School
Geverifieerd e-mailadres voor partners.org
Titel
Geciteerd door
Geciteerd door
Jaar
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors
LV Sequist, BA Waltman, D Dias-Santagata, S Digumarthy, AB Turke, ...
Science translational medicine 3 (75), 75ra26-75ra26, 2011
35602011
Non–small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology
DS Ettinger, DE Wood, DL Aisner, W Akerley, J Bauman, LR Chirieac, ...
Journal of the National Comprehensive Cancer Network 15 (4), 504-535, 2017
11502017
Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes
H Zhuang, M Pourdehnad, ES Lambright, AJ Yamamoto, M Lanuti, P Li, ...
Journal of Nuclear Medicine 42 (9), 1412-1417, 2001
7842001
NCCN guidelines insights: non–small cell lung cancer, version 2.2021: featured updates to the NCCN guidelines
DS Ettinger, DE Wood, DL Aisner, W Akerley, JR Bauman, A Bharat, ...
Journal of the National Comprehensive Cancer Network 19 (3), 254-266, 2021
6962021
NCCN guidelines insights: non–small cell lung cancer, version 1.2020: featured updates to the NCCN guidelines
DS Ettinger, DE Wood, C Aggarwal, DL Aisner, W Akerley, JR Bauman, ...
Journal of the National Comprehensive Cancer Network 17 (12), 1464-1472, 2019
6372019
Non–small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology
DS Ettinger, DE Wood, DL Aisner, W Akerley, JR Bauman, A Bharat, ...
Journal of the National Comprehensive Cancer Network 20 (5), 497-530, 2022
4962022
NCCN guidelines insights: non–small cell lung cancer, version 5.2018
DS Ettinger, DL Aisner, DE Wood, W Akerley, J Bauman, JY Chang, ...
Journal of the National Comprehensive Cancer Network 16 (7), 807-821, 2018
4912018
Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice
LV Sequist, RS Heist, AT Shaw, P Fidias, R Rosovsky, JS Temel, ...
Annals of Oncology 22 (12), 2616-2624, 2011
4652011
NCCN guidelines insights: non–small cell lung cancer, version 4.2016
DS Ettinger, DE Wood, W Akerley, LA Bazhenova, H Borghaei, ...
Journal of the National Comprehensive Cancer Network 14 (3), 255-264, 2016
4502016
Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial
CA Shu, JF Gainor, MM Awad, C Chiuzan, CM Grigg, A Pabani, ...
The Lancet Oncology 21 (6), 786-795, 2020
4242020
Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells
BC Fuchs, T Fujii, JD Dorfman, JM Goodwin, AX Zhu, M Lanuti, ...
Cancer research 68 (7), 2391-2399, 2008
3982008
Non–small cell lung cancer, version 6.2015
DS Ettinger, DE Wood, W Akerley, LA Bazhenova, H Borghaei, ...
Journal of the National Comprehensive Cancer Network 13 (5), 515-524, 2015
3972015
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma
BC Fuchs, Y Hoshida, T Fujii, L Wei, S Yamada, GY Lauwers, CM McGinn, ...
Hepatology 59 (4), 1577-1590, 2014
3232014
Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis
KK Tanabe, A Lemoine, DM Finkelstein, H Kawasaki, T Fujii, RT Chung, ...
Jama 299 (1), 53-60, 2008
2522008
Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma
KL Molnar-Kimber, DH Sterman, M Chang, EH Kang, M ElBash, M Lanuti, ...
Human gene therapy 9 (14), 2121-2133, 1998
2241998
Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor
T Fujii, BC Fuchs, S Yamada, GY Lauwers, Y Kulu, JM Goodwin, M Lanuti, ...
BMC gastroenterology 10, 1-11, 2010
2212010
Non–small cell lung cancer, version 1.2015
DS Ettinger, DE Wood, W Akerley, LA Bazhenova, H Borghaei, ...
Journal of the National Comprehensive Cancer Network 12 (12), 1738-1761, 2014
2202014
SELECT: a phase II trial of adjuvant erlotinib in patients with resected epidermal growth factor receptor–mutant non–small-cell lung cancer
NA Pennell, JW Neal, JE Chaft, CG Azzoli, PA Jšnne, R Govindan, ...
Journal of Clinical Oncology 37 (2), 97, 2019
1942019
Molecular liver cancer prevention in cirrhosis by organ transcriptome analysis and lysophosphatidic acid pathway inhibition
S Nakagawa, L Wei, WM Song, T Higashi, S Ghoshal, RS Kim, CB Bian, ...
Cancer cell 30 (6), 879-890, 2016
1792016
Radiofrequency ablation for treatment of medically inoperable stage I non–small cell lung cancer
M Lanuti, A Sharma, SR Digumarthy, CD Wright, DM Donahue, JC Wain, ...
The Journal of thoracic and cardiovascular surgery 137 (1), 160-166, 2009
1772009
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20